Stock Symbol:

VRUS

Company Name:

Pharmasset, Inc.

Company Description:

Pharmasset, Inc. is a clinical-stage pharmaceutical company, focuses on discovering, developing, and commercializing novel drugs to treat viral infections. Its primary focus is on the development of nucleoside/tide analogs as oral therapeutics for the treatment of chronic hepatitis C virus (HCV) infection.

Investment Sector:

Biotechnology and Drugs

Predicted Split Months:

F-M-A-N

Stock Exchange:

NASDAQ

Predicted Split Price:

$87.00

Predicted Split Ratio:

2 for 1

5 Day Performance After Split:

3.2%

Prior Stock Splits:

0

Stock Split History:

None

Split Predictions Are Based Upon Historical Stock Market Data And Sector Trends. This Data Is For Educational Purposes Only.